08:00 , Feb 16, 2015 |  BC Week In Review  |  Company News

Aquarius Biotechnologies, Matinas BioPharma deal

Aquarius’ lead products are CAmB ( MAT2203 ), a lipid-crystal nano-particle formulation of amphotericin B in development to treat oral fungal infection; and C-Amikacin ( MAT2501 ), a preclinical lipid-crystal nano-particle formulation of Amikacin in...